New device expands access to the latest technology for legacy VNS Therapy patients with drug-resistant epilepsy in the U.S. LONDON --(BUSINESS WIRE)--Feb. 2, 2023-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today launched SenTiva DUO™, an implantable

LONDON --(BUSINESS WIRE)--Jan. 18, 2023-- LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2022 results on Wednesday, February 22, 2023 at 1 p.m.   London time ( 8 a.m. Eastern Time ).